Zurcher Kantonalbank (Zurich Cantonalbank) - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 8 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2012. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$103,000
-9.6%
8,3110.0%0.00%0.0%
Q3 2016$114,000
+256.2%
8,311
+93.5%
0.00%
Q2 2016$32,000
+18.5%
4,2960.0%0.00%
Q1 2016$27,0000.0%4,2960.0%0.00%
Q4 2015$27,000
+145.5%
4,296
+119.4%
0.00%
Q3 2015$11,000
+57.1%
1,958
+140.2%
0.00%
Q2 2015$7,0000.0%8150.0%0.00%
Q1 2015$7,000
-99.6%
815
-99.7%
0.00%
-100.0%
Q2 2014$1,911,000
+18.5%
300,000
+50.0%
0.06%
+12.0%
Q1 2014$1,612,000
+18.2%
200,0000.0%0.05%
+11.1%
Q4 2013$1,364,000
-48.9%
200,000
+37.9%
0.04%
-51.1%
Q3 2013$2,668,000
-19.7%
145,000
-23.7%
0.09%
-20.7%
Q2 2013$3,323,000
+53.1%
190,000
+58.3%
0.12%
+52.6%
Q1 2013$2,171,000
+13.2%
120,000
+20.0%
0.08%
+1.3%
Q4 2012$1,918,000
-13.0%
100,000
+9.9%
0.08%
-15.7%
Q3 2012$2,205,000
+40.8%
91,0000.0%0.09%
+27.1%
Q2 2012$1,566,000
+7.9%
91,0000.0%0.07%
+7.7%
Q1 2012$1,452,000
+97.6%
91,000
+51.7%
0.06%
+91.2%
Q4 2011$735,00060,0000.03%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2012
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,000,000$96,720,00033.30%
Opaleye Management Inc. 1,670,000$13,460,0009.94%
Slate Path Capital LP 6,620,000$53,357,0004.04%
Granite Point Capital Management, L.P. 648,000$5,223,0003.74%
Palo Alto Investors LP 6,917,248$55,754,0002.30%
Camber Capital Management LP 3,000,000$24,180,0001.90%
Geduld E E 277,600$2,237,0001.21%
Elk Creek Partners, LLC 290,886$2,345,0001.01%
SELZ CAPITAL LLC 400,000$3,224,0000.81%
GENERAL AMERICAN INVESTORS CO INC 1,200,000$9,672,0000.81%
View complete list of ARIAD PHARMACEUTICALS INC shareholders